[Molecular structure, regulatory mechanism and biological activity of endothelial nitric oxide synthase].
Miyamoto
Yoshihiro
Y
Department of Atherosclerosis and Diabetes, National Cardiovascular Center.
D000818:Animals; D001161:Arteriosclerosis / Q000209:etiology; D002118:Calcium / Q000502:physiology; D051242:Caveolin 1; D022461:Caveolins / Q000378:metabolism; D006152:Cyclic GMP / Q000378:metabolism; D042783:Endothelial Cells / Q000201:enzymology / Q000378:metabolism; D015870:Gene Expression / Q000187:drug effects; D006162:Guanylate Cyclase; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology; D009154:Mutation; D009569:Nitric Oxide / Q000096:biosynthesis / Q000502:physiology; D019001:Nitric Oxide Synthase / Q000235:genetics / Q000502:physiology*; D052250:Nitric Oxide Synthase Type III; D018160:Receptors, Cytoplasmic and Nuclear / Q000378:metabolism; D000071756:Soluble Guanylyl Cyclase; D014158:Transcription, Genetic
D051242:Caveolin 1; D022461:Caveolins; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D018160:Receptors, Cytoplasmic and Nuclear; D009569:Nitric Oxide; C496314:NOS3 protein, human; D019001:Nitric Oxide Synthase; D052250:Nitric Oxide Synthase Type III; D006162:Guanylate Cyclase; D000071756:Soluble Guanylyl Cyclase; D006152:Cyclic GMP; D002118:Calcium